These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15306743)

  • 1. A rationale for the use of anticoagulation in heart failure management.
    Pulerwitz T; Rabbani LE; Pinney SP
    J Thromb Thrombolysis; 2004 Apr; 17(2):87-93. PubMed ID: 15306743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
    Sandhu RK; Hohnloser SH; Pfeffer MA; Yuan F; Hart RG; Yusuf S; Connolly SJ; McAlister FA; Healey JS
    Stroke; 2015 Mar; 46(3):667-72. PubMed ID: 25628308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction.
    Baker DW; Wright RF
    JAMA; 1994 Nov 23-30; 272(20):1614-8. PubMed ID: 7966873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation Therapy and NOACs in Heart Failure.
    Thomas I; EncisoSilva J; Schlueter M; Greenberg B
    Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolism in heart failure: who should be treated?
    Diet F; Erdmann E
    Eur J Heart Fail; 2000 Dec; 2(4):355-63. PubMed ID: 11113711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant therapy in patients with dilated cardiomyopathy].
    Gensini GF; Rostagno C
    Ann Ital Med Int; 1998; 13(4):227-32. PubMed ID: 10349204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation and heart failure.
    Graham SP
    Curr Cardiol Rep; 2001 Jan; 3(1):72-7. PubMed ID: 11139802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
    Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P
    Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin, oral anticoagulants, and heart failure].
    Gibelin P
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1377-81. PubMed ID: 9864607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilated cardiomyopathy and role of antithrombotic therapy.
    Abdo AS; Kemp R; Barham J; Geraci SA
    Am J Med Sci; 2010 Jun; 339(6):557-60. PubMed ID: 20186041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.
    Wipf JE
    West J Med; 1995 Aug; 163(2):145-52. PubMed ID: 7571562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation in patients with heart failure.
    Bhatia RS; Ouzounian M; Tu JV; Liu PP; Lee DS
    Cardiovasc Hematol Agents Med Chem; 2009 Jul; 7(3):193-7. PubMed ID: 19689257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
    Prom R; Usedom JE; Dull RB
    Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
    Garwood CL; Hwang JM; Moser LR
    Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic heart failure- potential for pharmacological intervention.
    De Lorenzo F; Kakkar VV
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):149-55. PubMed ID: 15853701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulation in chronic heart failure and left ventricular dysfunction].
    Wichter T; Breithardt G
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.